Citadel Advisors’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-300
Closed -$13.1K – 12970
2025
Q1
$13.1K Buy
+300
New +$13.1K ﹤0.01% 13416
2024
Q4
– Sell
-4,800
Closed -$214K – 14651
2024
Q3
$214K Buy
+4,800
New +$199K ﹤0.01% 10003

Other funds holding DBD

Citadel Advisors's DBD Position: Q3 2026 in Review

Citadel Advisors increased its Diebold Nixdorf (DBD) stake by 2,716% in Q3 2026, buying an estimated $5.42M and bringing the position to 76,520 shares worth $4.68M. The position accounts for ﹤0.01% of the portfolio, ranked #4964.

Citadel Advisors first reported a position in DBD in Q3 2023 and has held it in 11 quarters since. The position peaked at $8.53M in Q1 2026. 215 funds tracked by Wall St. Rank hold DBD as of Q3 2026.

  • Citadel Advisors held 76,520 shares of Diebold Nixdorf worth $4.68M as of Q3 2026.
  • Citadel Advisors bought 73,803 Diebold Nixdorf shares in Q3 2026, an estimated $5.42M.
  • Diebold Nixdorf made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #4964 holding.
  • Citadel Advisors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 11 quarters since.
  • Citadel Advisors's Diebold Nixdorf position peaked at $8.53M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.